01 1Zhejiang Huahai Pharmaceutical
01 1LEVODOPA USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-07-31
Pay. Date : 2017-06-01
DMF Number : 31612
Submission : 2017-05-11
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVODOPA USP, with a corresponding US DMF Number 31612.
Remarkably, this DMF maintains an Active status since its submission on May 11, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2017, and payment made on June 01, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
